APR 1, 2026 · REGULATORY LABEL UPDATE
FDA supplemental approval: Prochlorperazine Edisylate (Labeling)
U.S. Food and Drug Administration
FDA supplemental approval for labeling update to prochlorperazine edisylate injectable; this is a regulatory action, not a clinical trial, and does not contain efficacy or safety evidence.